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Relationship between diabetic retinopathy severity
and the timespan between the endocrinopathy
diagnosis and the first ophthalmic examination
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Purpose: To investigate whether the time interval between type 2 diabetes
mellitus (DM) diagnosis and the first fundoscopic examination is related
with the presence and the severity of diabetic retinopathy (DR) observed.
Methods: A survey of 105 type 2 DM patients referred to ophthalmologic
evaluation in the “Hospital das Clinicas” (HC), University of São Paulo
Medical School (USPMS). Results: Regarding classification of DR in the
105 patients, 15 (14.28%) did not show signs of DR, and 90 (85.72%)
exhibited them on fundoscopy. Sixty patients underwent laser therapy,
and 46.66% reported poor control of DM. Only 15.23% of DM patients
were adequately screened for DR on the first year of their DM diagnosis.
Among the 36 patients (34.30%) examined within five years of DM
diagnosis, 58.33% did not present or demonstrate signs of mild DR and
22.20%  of proliferative DR; 30 patients underwent an ophthalmologic
examination after more than eleven years of DM diagnosis, 21.62% did
not exhibit signs of DR and 59.46% were classified as proliferative DR.
Conclusion: This study showed a statistically significant relationship
between the time interval from the diagnosis of type 2 DM and the first
fundoscopic examination with the severity of DR.
ABSTRACT
INTRODUCTION
Diabetic retinopathy (DR) is the leading cause of visual acuity reduc-
tion in the United States(1-2). In Brazil, it has been estimated that half of the
patients with DM suffer from DR and 7.5% of them are unable to work(3).
Knowledge of the risk factors that lead to DR and its progression are therefore
extremely important for preventing visual loss(4) and clinical studies have
shown that inadequate plasma glucose control is associated with an
increase in DR severity(5-6). On the other hand, the United Kingdom Pros-
pective Diabetic Study (UKPDS) has shown that intensive glycemic con-
trol can decrease the risk of visual loss in type 2 diabetes patients(7).
The duration of DM is also a significant risk factor for the development
of DR, after 20 years of DM 60% of type 2 DM patients have some degree
of DR(8). On the other hand, DR is rarely present in the first years after the
diagnosis of DM. Based on such data, the American Academy of Ophthal-
mology (AAO) recommends that the first fundus examination in type 1
diabetics should be performed five years after the disease diagnosis(9), as
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DR is rarely observed before that time period(10-11). Never-
theless, subjects with type 2 DM frequently are unable to
accurately define when diabetes was first diagnosed and
therefore DR may already be present at the time of diagno-
sis(12).  In such patients, fundus examination has been recom-
mended to be performed soon after the diagnosis of DM is
established(9).
Considering that DM may be present long before the
disease is diagnosed and that endocrinologists tends to en-
force stricter control of DM only after the ophthalmologic
examination confirms the presence of DR(13), we have hypo-
thesized that the later the fundus examination is first perfor-
med, the greater the severity of DR would be. The purpose of
this paper was therefore to investigate whether the time inter-
val between type 2 DM diagnosis and the first fundoscopic
examination is related with the presence and the severity of
DR observed.
METHODS
During a four-month period of time, 105 sequential pa-
tients with type 2 DM referred to the division of Ophthalmo-
logy of the University of São Paulo Medical School for oph-
thalmologic evaluation were asked to fill out a questionnaire
and subsequently submitted to a complete fundoscopic exa-
mination. Questions were formulated to obtain information
regarding the time elapsed since diabetes mellitus was first
diagnosed; when was the first ophthalmoscopic examination
performed; and whether laser treatment had already been
performed. Patients were also asked whether they considered
their DM under control, based on information obtained on
the last medical evaluation. The quality of DM control (ade-
quate or poor control) was based on patient’s information
based on results of previous laboratory examination. The
study followed the principles of the Declaration of Helsinki.
Approval from the Institutional Review Board Ethics Com-
mittee was obtained and all participants gave their informed
consent.
Using a slit lamp and a 78 dioptries Volk® lens, a retinal
specialist performed the fundus examination of all patients
after pupil dilatation with 10% phenylephrine and 1% tropi-
camide. DR was diagnosed and classified according to the
severity scales recommended by the AAO. Each patient was
classified as proliferative or non-proliferative disease(14).
Data obtained from the patients in the questionnaire were
compared with the recommendations of the AAO(4). Patients
submitted to a fundoscopic evaluation within one year of
diagnosis of DM were considered to match the AAO recom-
mendations (correct management while those that were refer-
red more than one year after DM diagnosis were not correct).
The numerical variables were represented by mean value
± standard deviation while categorical variables were descri-
bed by absolute and relative frequencies. The chi-square test
was employed for comparisons between groups. The correla-
tion between the severity of DR and the time elapsed between
the diagnosis of DM and the first fundoscopic examination
was assessed using. A p value of less than 0.05 was conside-
red statistically significant.
RESULTS
Of the 105 subjects, 45.71% were male and 54.29% fema-
le. The mean standard deviation age was 63.5 ± 10.0 years
(range, 41 - 86). Of 105 examined patients, 15 (14.28%) had
no signs of DR, 30 (28.57%) showed mild non-proliferative
DR, 18 (17.14%) moderate non-proliferative DR, 5 (4.76 %)
severe or very serious non-proliferative DR and 37 (35.24%)
proliferative DR. Sixty (57.14%) of the 105 patients reported
prior laser photocoagulation treatment.
Only 19 patients had their first fundoscopic examination
within one year of DM diagnosis. The relationship between
the time interval between DM diagnosis and the first FE with
the classification of DR are listed on table 1. Patients with a
greater time interval between DM diagnosis and the first FE
showed a significant association with the severity of DR
(p<0.001) (Table 1).
Table 2 demonstrates the relationship between the time in-
terval of the DM diagnosis and the correct time of the first FE. It
was noted that the shorter the time interval of DM diagnosis, the
earlier the examination was performed (p<0.001).
After collecting data regarding the control of DM, these
data were compared with the degree of DR classification.
Among 105 patients, 67.62% stated their DM was under con-
trol and 32.38% believed their DM had a poor control. Of the
patients that indicated an adequate DM control, 21.12% had
no signs of DR, 50.70% had non-proliferative DR and 28.18%
had proliferative DR. All patients that referred poor DM
control had DR on fundus examination; proliferative DR was
present in 47.05% and non-proliferative in 52.95%.
Table 3 compares the subjects that had already been treated
with laser therapy and their report regarding the quality of DM
control. Of the 60 patients with prior laser photocoagulation,
28 (46.66%) mentioned unsuccessful DM control. There was a
significant association between the severity of DR and the
type of DM control. Patients with less severe retinopathy were
those that reported adequate control of DM (p<0.001).
DISCUSSION
Ophthalmologic complications of DM are very common
and may be severe(15), occurring in approximately 50% of the
patients(16). In the current study, 80% of 105 examined pa-
tients revealed signs of DR, a much higher prevalence when
compared with the study of Fernandez et al. 1998(17) that
found DR in 34.5% of 605 DM patients evaluated. This high
proportion may be due to the fact that our sample was taken
from a retinal specialist clinic.
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The patients that did not follow the suggestions of the
AAO(9) regarding the first FE examination after the diagnosis of
DM, showed greater severity of DR (p<0.001, chi-square test).
Since general practitioners and/or endocrinologists usually do
not adopt stricter treatments for DM until the ophthalmologic
examination confirms the presence of DR, as demonstrated in
one of our previous work(13) and since inadequate plasma glu-
cose control is associated with an increase in DR severity(5-6),
not performing early fundoscopic examination in the disease
not only causes a delay in the treatment of possible DR but also
represents a lack of opportunity to stress adequate DM control
for those with some signs of retinopathy.
This study suggests that the indication for the first FE
(Table 2) in diabetic subjects has been improving over the
years, since the results demonstrate that the shorter the diag-
nostic time interval of the DR, the earlier the first FE was
accomplished. It is impressive that 90.25% of patients diag-
nosed with DM over 15 years ago underwent the first FE after
1 year of the diagnosis of their disease.
Table 3 illustrates that in spite of having undergone laser
photocoagulation, 46.66% considered that their disease was
still uncontrolled, demonstrating failure to comply with treat-
ment. On the other hand, only 13.34% of those that had not
been treated mentioned lack of control. Among those that
mentioned control of DM, most of the patients (21.12%) did
not display signs of DR. All patients that reported poor DM
control presented signs of DR. This suggests that the better
the DM control, the lower the severity of DR, a fact already
confirmed by the important UKPDS study(7). These numbers
have some limitation due to the absence of complementary test.
The individuals evaluated in this study are far from the ideal
ophthalmologic management advocated for type 2 diabetic
patients, and only 15% are close to the recommendations(9).
All this leads to considerations about various flaws in the
follow-up care of these patients such as the inadequacy of
information, their lack of interest regarding this illness, diffi-
culty of access to public health care and even unawareness by
general practitioners and endocrinologists about the correct
indication of the FE for DM patients(17).
Since laser therapy is a procedure that can cause ocular
complication, it is extremely important that all possible fac-
tors of DM control be put into practice in order for this treat-
ment to be deferred for as long as possible.
In conclusion, this study showed a statistically signifi-
cant relationship between the time interval from the diagno-
sis of type 2 DM and the first fundoscopic examination and
the severity of DR. Clinicians and ophthalmologist should en-
courage type 2 DM patients to undergo fundus examination
soon after the diagnosis of DM is established in order to faci-
litate earlier detection and treatment of diabetic retinopathy.
RESUMO
Objetivo: Avaliar se o tempo de intervalo entre o diagnóstico
do diabetes mellitus (DM) tipo 2 e o primeiro exame de fundo
de olho está relacionado com a gravidade da retinopatia dia-
bética (RD). Métodos: Inquérito realizado em 105 pacientes
portadores de DM tipo 2 que foram referenciados para avalia-
ção oftalmológica no Hospital das Clínicas da Faculdade de
Medicina da Universidade de São Paulo. Resultados: Quanto à
classificação da RD, dos 105 pacientes, 15 (14,28%) não apre-
sentavam sinais de RD e 90 (85,72%) demonstraram presença
de sinais de RD ao exame de fundo de olho. Somente 15,23%
dos pacientes avaliados foram examinados no primeiro ano do
diagnóstico de DM. Sessenta pacientes foram submetidos à
laserterapia, 46,66% relataram mal controle do DM. Quando
examinados em até 5 anos de diagnóstico de DM, 36 (34,30%),
Table 1. Relationship between classification of retinopathy and time interval  between the diagnosis and the first fundoscopy
Classification Time interval (months)
(considering the eye in a more advanced stage) 1 to 59 60 to 120 ≥ 132
No signs of retinopathy 11 (73.33%) 3 (20.00%) 1 (  6.67%)
Mild non-proliferative diabetic retinopathy 10 (33.33%) 19 (63.33%) 1 (  3.34%)
Moderate non-proliferative diabetic retinopathy 6 (33.33%) 9 (50.00%) 3 (16.64%)
Severe non-proliferative diabetic retinopathy 1 (20.00%) 1 (20.00%) 3 (60.00%)
Proliferative diabetic retinopathy 8 (21.62%) 7 (18.92%) 22 (59.46%)
Table 2. Relationship between duration of diabetes and the first
fundoscopic examination
Time of diagnosis Correct time of first
(months) fundoscopic eye examination
(1 years of  diagnosis of DM)
1 a 72 Correct= 12 (44.44%)
Incorrect= 15 (65.56%)
73 a 180 Correct= 3 (  8.11%)
Incorrect= 34 (91.89%)
>180 Correct= 4 (  9.75%)
Incorrect= 37 (90.25%)
Table 3. Relationship between laser therapy and disease control
Treated Control of disease
Yes Yes = 32 (53.33%)
No = 28 (46.67%)
No Yes = 39 (86.66%)
No = 6 (13.34%)
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pacientes, 58,33% não apresentaram sinais ou demonstravam
sinais de RD grau leve e 22,20% RD proliferativa. Trinta
pacientes receberam exame oftalmológico superior a 11 anos
do diagnóstico de DM, 21,62% não apresentavam sinais de
RD e 59,46% classificados com RD proliferativa. Conclusão:
Este estudo demonstrou significância estatística na relação
entre o intervalo de tempo do diagnóstico do DM tipo 2 e o
primeiro exame de fundo de olho com a gravidade de RD.
Descritores: Diabetes mellitus; Retinopatia diabética
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